Recursion Pharmaceuticals Inc Cl A (RXRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | RXRX | AZN | AMGN | GILD | VRTX |
| Company | Recursion Pharmaceuticals Inc Cl A | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NASDAQ |
| Open | 3.37 | 157.68 | 413.31 | 133.99 | 527.00 |
| High | 3.38 | 159.02 | 418.19 | 137.12 | 531.22 |
| Low | 3.26 | 157.12 | 409.00 | 133.30 | 520.08 |
| Last | 3.29 | 157.34 | 417.10 | 136.78 | 529.11 |
| Change | -0.06 | -1.41 | +2.80 | +1.01 | -0.54 |
| Percent Change | -1.79% | -0.89% | +0.68% | +0.74% | -0.10% |
| Volume | 4,477,749 | 1,678,221 | 476,246 | 1,759,281 | 263,437 |
| 20-Day Average Volume | 17,128,260 | 3,799,794 | 2,644,227 | 6,847,321 | 1,345,734 |
| Previous | 3.35 | 158.75 | 414.30 | 135.77 | 529.65 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 3.10 | 165.60 | 387.65 | 132.59 | 488.34 |
| 20-Day Raw Stochastic | 78.17% | 21.37% | 92.99% | 72.77% | 80.31% |
| 20-Day Relative Strength | 51.45 | 38.08 | 70.00 | 57.33 | 67.65 |
| Weighted Alpha | -39.11 | -9.44 | +45.80 | +14.95 | +37.66 |
| Today's Opinion | 64% Sell | 100% Sell | 100% Buy | 56% Buy | 100% Buy |
| Yesterday's Opinion | 40% Sell | 100% Sell | 100% Buy | 40% Buy | 100% Buy |
| Last Month's Opinion | 48% Sell | 88% Sell | 56% Buy | 40% Sell | 72% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +3.89% since 08/05/26 | -2.15% since 08/05/26 | +2.32% since 08/05/26 | +4.03% since 08/05/26 | +9.35% since 08/05/26 |
| Low | 3.12 on 08/06/26 | 157.16 on 08/12/26 | 401.07 on 08/07/26 | 129.02 on 08/06/26 | 480.86 on 08/06/26 |
| High | 3.42 on 08/11/26 | 162.93 on 08/06/26 | 421.79 on 08/11/26 | 137.11 on 08/12/26 | 546.17 on 08/10/26 |
| 1-Month | |||||
| %Chg | -7.49% since 07/10/26 | -7.91% since 07/10/26 | +14.84% since 07/10/26 | +5.58% since 07/10/26 | +9.23% since 07/10/26 |
| Low | 2.84 on 07/20/26 | 153.41 on 08/03/26 | 353.95 on 07/15/26 | 127.61 on 07/23/26 | 465.00 on 07/23/26 |
| High | 3.54 on 07/13/26 | 175.04 on 07/29/26 | 421.79 on 08/11/26 | 140.61 on 07/17/26 | 546.17 on 08/10/26 |
| 3-Month | |||||
| %Chg | +4.55% since 05/12/26 | -14.36% since 05/12/26 | +24.09% since 05/12/26 | +1.58% since 05/12/26 | +18.27% since 05/12/26 |
| Low | 2.77 on 05/19/26 | 153.41 on 08/03/26 | 320.96 on 05/19/26 | 121.39 on 06/10/26 | 420.01 on 06/03/26 |
| High | 4.09 on 07/06/26 | 196.41 on 07/02/26 | 421.79 on 08/11/26 | 140.61 on 07/17/26 | 546.17 on 08/10/26 |
| 6-Month | |||||
| %Chg | -8.01% since 02/12/26 | -22.73% since 02/12/26 | +13.95% since 02/12/26 | -9.71% since 02/12/26 | +14.01% since 02/12/26 |
| Low | 2.77 on 05/19/26 | 153.41 on 08/03/26 | 320.52 on 05/05/26 | 121.39 on 06/10/26 | 412.27 on 05/05/26 |
| High | 4.09 on 07/06/26 | 212.71 on 02/18/26 | 421.79 on 08/11/26 | 156.95 on 02/13/26 | 546.17 on 08/10/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 1,775,182 | 246,206,640 | 223,983,840 | 168,348,672 | 134,427,824 |
| Shares Outstanding, K | 529,905 | 1,550,908 | 540,632 | 1,239,955 | 253,805 |
| Annual Sales, $M | 74,680,000 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 12,001,300,000 |
| Annual Net Income, $M | -644,760,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 3,953,200,000 |
| Last Qtr Sales, $M | 7,670,000 | 15,384,000,000 | 10,054,000,000 | 7,803,000,000 | 3,333,900,000 |
| Last Qtr Income, $M | -131,010,000 | 2,507,000,000 | 2,375,000,000 | -10,496,000,000 | 1,099,800,000 |
| 60-Month Beta | 1.03 | 0.26 | 0.41 | 0.32 | 0.30 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.25 on 08/05/26 | 2.63 on 07/27/26 | 6.29 on 08/04/26 | -6.75 on 08/04/26 | 4.73 on 08/03/26 |
| Latest Earnings Date | 11/04/26 | 11/05/26 | 11/03/26 | 10/29/26 | 11/02/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 05/15/26 | 0.820 on 06/15/26 | N/A |
| Next Ex-Dividend Date | N/A | 02/20/26 | 08/21/26 | 09/15/26 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 16.67 | 18.65 | 0.00 | 30.78 |